Within the tumor, the highest absolute counts of Tregs and proportion of total CD45 + cells were found in the combination treatment group (Fig. 3a, Online Resource Figure S1a), which was significantly greater compared to untreated controls (p < 0.001) and anti-mCTLA-4 (p < 0.001). The gene discussed is PTPRC; the disease is neoplasm.